2019 American Transplant Congress
Routine Molecular Clostridioides difficile Screening and Overtreatment in Solid Organ Transplant Recipients
*Purpose: The objective of this analysis is to determine how frequently positive Clostridioides difficile (CD) screening tests, potentially identifying up to 20% of inpatients with…2019 American Transplant Congress
The Impact of Antibiotic Therapy on Clinical Outcomes in Kidney Transplant Recipients with Asymptomatic Bacteriuria
1Michigan Medicine, Ann Arbor, MI, 2MedStar Georgetown University Hospital, Washington, DC
*Purpose: Asymptomatic bacteriuria (ASB) occurs in nearly 50% of kidney transplant recipients (KTRs) in the first year post-transplant. Data evaluating the risk of untreated ASB…2019 American Transplant Congress
Comparison of Proton Pump Inhibitors versus Histamine-2-Receptor Antagonists on Clostridium difficile Rates in Liver Transplant Recipients
Lahey Hospital and Medical Center, Burlington, MA
*Purpose: To determine if there is a difference in 90 day Clostridium difficile infection (CDI) rates before and after the stress ulcer prophylaxis (SUP) protocol…2019 American Transplant Congress
Utility of Gallium-67 Single Photon Emission Computed Tomography in the Evaluation of Left Ventricular Assist Device Infections
*Purpose: We routinely use gallium-67 single photon emission computed tomography (67Ga-SPECT-CT) to determine the presence and extent of left ventricular assist device (LVAD) infections. The…2019 American Transplant Congress
Kidney Transplantation in Patients with Neurogenic Bladder
Clinical Hospital Merkur, 10000 Zagreb, Croatia
*Purpose: Neurogenic bladder is a condition associated with high incidence of urinary tract infections (UTI). Infections in immunocompromised patients can be life-threatening and result in…2019 American Transplant Congress
Efficacy and Safety of Alemtuzumab versus Basiliximab Induction in Lung Transplantation
Temple University Hospital, Philadelphia, PA
*Purpose: Minimal literature exists regarding alemtuzumab for induction in lung transplantation but is the preferred agent at Temple University Hospital (TUH). Basiliximab is reserved for…2019 American Transplant Congress
Contemporary US Prevalence and Outcomes of Pneumocystis jirovecii Pneumonia and Toxoplasmosis in Pediatric Solid Organ and Hematopoietic Cell Transplantation Recipients
*Purpose: We sought to evaluate the contemporary prevalence and outcomes of Pneumocystis jirovecii pneumonia (PCP) and toxoplasmosis among pediatric transplantation recipients in the US in…2019 American Transplant Congress
Infectious Complications in Tocilizumab-Treated Kidney Transplant Recipients
Cedars Sinai Medical Center, Los Angeles, CA
*Purpose: Tocilizumab blocks IL-6 signaling, inhibiting maturation of B cells to plasma cells and antibody production. We have used tocilizumab since 2012 to treat kidney…2019 American Transplant Congress
Predictors of Clostridium difficile Infection and Recurrence among 2,622 Solid Organ Transplant Recipients
Columbia University, New York, NY
*Purpose: Clostridium difficile infection (CDI) is common after solid organ transplant (SOT) and is associated with high morbidity and mortality. We assessed incidence, risk factors…2019 American Transplant Congress
What is the Post-Heart Transplant Risk of Infectious Complications from Pre-Transplant Desensitization Therapy?
Cedars-Sinai Smidt Heart Institute, Los Angeles, CA
*Purpose: Sensitization or the detection of circulating antibodies in heart transplant candidates appears to be increasing due to the growing use of mechanical circulatory support…
- « Previous Page
- 1
- …
- 45
- 46
- 47
- 48
- 49
- …
- 84
- Next Page »